HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 368: | Line 368: | ||
|Acute myeloid leukaemia with CEBPA mutation | |Acute myeloid leukaemia with CEBPA mutation | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 376: | Line 376: | ||
| | | | ||
| | | | ||
| | |Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA | ||
| | |Paul Defazio, MSc, Monash Health | ||
| | |Complete | ||
| | | | ||
| | | | ||
| Line 384: | Line 384: | ||
|Acute myeloid leukaemia, myelodysplasia-related | |Acute myeloid leukaemia, myelodysplasia-related | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 392: | Line 392: | ||
| | | | ||
| | | | ||
| | |Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes | ||
| | |Fei Yang, MD, FACMG <br> Oregon Health & Science University | ||
| | |Complete | ||
| | | | ||
| | | | ||
| Line 408: | Line 408: | ||
| | | | ||
| | | | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|Acute myeloid leukaemia with minimal differentiation | |Acute myeloid leukaemia with minimal differentiation | ||
| Line 424: | Line 424: | ||
| | | | ||
| | | | ||
| | |Acute Myeloid Leukemia (AML) with Minimal Differentiation | ||
| | |Celeste Eno, PhD, Cedars Sinai Medical Center, Los Angeles, Fabiola Quintero-Rivera, MD, FACMG, University of California Irvine | ||
| | |Complete | ||
| | | | ||
| | | | ||
| Line 440: | Line 440: | ||
| | | | ||
| | | | ||
| | |Acute Myeloid Leukemia (AML) without Maturation | ||
| | |Jennelle C. Hodge, PhD, FACMG | ||
| | |Complete | ||
| | | | ||
| | | | ||
| Line 456: | Line 456: | ||
| | | | ||
| | | | ||
| | |Acute Myeloid Leukemia (AML) with Maturation | ||
| | |Jennelle C. Hodge, PhD, FACMG | ||
| | |Complete | ||
| | | | ||
| | | | ||